Investigational Drug Information for Halofuginone
✉ Email this page to a colleague
What is the development status for investigational drug Halofuginone?
Halofuginone is an investigational drug.
There have been 5 clinical trials for Halofuginone.
The most recent clinical trial was a Phase 2 trial, which was initiated on October 1st 2013.
The most common disease conditions in clinical trials are Muscular Dystrophy, Duchenne, Muscular Dystrophies, and Sarcoma, Kaposi. The leading clinical trial sponsors are Akashi Therapeutics, Processa Pharmaceuticals, and European Organisation for Research and Treatment of Cancer - EORTC.
There are six hundred and fifty-five US patents protecting this investigational drug and nine international patents.
Summary for Halofuginone
| US Patents | 655 |
| International Patents | 9,449 |
| US Patent Applications | 3,916 |
| WIPO Patent Applications | 1,411 |
| Japanese Patent Applications | 638 |
| Clinical Trial Progress | Phase 2 (2013-10-01) |
| Vendors | 48 |
Recent Clinical Trials for Halofuginone
| Title | Sponsor | Phase |
|---|---|---|
| HT-100 Long-term Study in DMD Patients Who Completed HALO-DMD-02 | Akashi Therapeutics | Phase 2 |
| Open Label Extension Study of HT-100 in Patients With DMD | Akashi Therapeutics | Phase 2 |
| Open Label Extension Study of HT-100 in Patients With DMD | Processa Pharmaceuticals | Phase 2 |
Clinical Trial Summary for Halofuginone
Top disease conditions for Halofuginone
Top clinical trial sponsors for Halofuginone
US Patents for Halofuginone
| Drugname | Patent Number | Patent Title | Patent Assignee | Estimated Expiration |
|---|---|---|---|---|
| Halofuginone | ⤷ Try a Trial | Formulations for tailored drug release | South Dakota Board of Regents (Pierre, SD) Sanford Health (Sioux Falls, SD) | ⤷ Try a Trial |
| Halofuginone | ⤷ Try a Trial | Substituted indole Mcl-1 inhibitors | Vanderbilt University (Nashville, TN) | ⤷ Try a Trial |
| Halofuginone | ⤷ Try a Trial | Cured gel and method of making | ATRIUM MEDICAL CORPORATION (Merrimack, NH) | ⤷ Try a Trial |
| >Drugname | >Patent Number | >Patent Title | >Patent Assignee | >Estimated Expiration |
International Patents for Halofuginone
| Drugname | Country | Document Number | Estimated Expiration | Related US Patent |
|---|---|---|---|---|
| Halofuginone | World Intellectual Property Organization (WIPO) | WO2016065255 | 2034-10-23 | ⤷ Try a Trial |
| Halofuginone | Canada | CA2922341 | 2033-08-28 | ⤷ Try a Trial |
| Halofuginone | European Patent Office | EP3038618 | 2033-08-28 | ⤷ Try a Trial |
| >Drugname | >Country | >Document Number | >Estimated Expiration | >Related US Patent |
